US 9758591
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted A61KA61K2039/505A61K2039/6081
Quick answer
US patent 9758591 (Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis) held by The Regents of the University of California expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K2039/6081, A61K39/001102, A61P